Drugs that contain Pantoprazole Sodium

1. Drug name - PROTONIX

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7550153 WYETH PHARMS Pantoprazole multiparticulate formulations Sep, 2024

(2 years from now)

US7553498 WYETH PHARMS Pantoprazole multiparticulate formulations Sep, 2024

(2 years from now)

US7838027 WYETH PHARMS Pantoprazole multiparticulate formulations Sep, 2024

(2 years from now)

US7553498

(Pediatric)

WYETH PHARMS Pantoprazole multiparticulate formulations Mar, 2025

(2 years from now)

US7550153

(Pediatric)

WYETH PHARMS Pantoprazole multiparticulate formulations Mar, 2025

(2 years from now)

US7838027

(Pediatric)

WYETH PHARMS Pantoprazole multiparticulate formulations Mar, 2025

(2 years from now)

US7544370 WYETH PHARMS Pantoprazole multiparticulate formulations Jun, 2026

(3 years from now)

US7544370

(Pediatric)

WYETH PHARMS Pantoprazole multiparticulate formulations Dec, 2026

(4 years from now)

Treatment: Erosive esophagitis, hypersecretory conditions including zollinger-ellison syndrome, maintenance of healing of erosive esophagitis and reduction of symptoms in patients with gerd

Dosage: FOR SUSPENSION, DELAYED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 40MG BASE FOR SUSPENSION, DELAYED RELEASE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.